Baxter nabs Prism's arrythmia drug in $338M buyout - FierceBiotech
Links shared publicly online about this topic.
- 356total visits
Baxter nabs Prism's arrythmia drug in $338M buyout - FierceBiotech
View full resource at fiercebiotech.com
Most Recently Shared on April 18, 2011 at 3:20 pm By:
Baxter nabs Prism's arrythmia drug in $338M buyout. http://bit.ly/eijgEe
Ligand Partner Prism Pharmaceuticals To Be Acquired By Baxter
medicalnewstoday.com — “Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) announced that its partner Prism Pharmaceuticals has entered into a definitive agreement to be acquired by Baxter International Inc. (NYSE:BAX).” View full resource at medicalnewstoday.com
Most Recently Shared on April 21, 2011 at 12:05 pm By:
Ligand Partner Prism Pharmaceuticals To Be Acquired By Baxter http://mnt.to/3TWm #pharma #pharmaceutical
Ligand Partner Prism Pharmaceuticals to be Acquired by Baxter - Drugs.com MedNews
drugs.com — “Baxter to Commercialize Nexterone Apr 20, 2011 - Ligand Pharmaceuticals Incorporated (NASDAQ LGND) announced that its partner Prism Pharmaceuticals has entered” View full resource at drugs.com
Most Recently Shared on April 20, 2011 at 2:03 pm By:
Ligand Partner Prism Pharmaceuticals to be Acquired by Baxter: Baxter to Commercialize Nexterone® SAN DIEG... http://bit.ly/ijuTTz #drug
UPDATE 1-Baxter to acquire Prism Pharma for $338 mln | Reuters
reuters.com — “* To pay $170 mln in cash, $168 mln in milestone payments * Deal to not materially impact 2011 results (Follows allerts) April 18 (Reuters) - Baxter International Inc saidit will acquire privately” View full resource at reuters.com
Most Recently Shared on April 18, 2011 at 2:37 pm By:
Baxter buying Prism Pharma in $338M deal. http://reut.rs/eJM4nV
Baxter U.S. - Baxter Announces the Acquisition of Prism Pharmaceuticals
baxter.com — “Baxter Announces the Acquisition of Prism Pharmaceuticals” View full resource at baxter.com
Most Recently Shared on April 18, 2011 at 1:13 pm By:
Baxter Announces the Acquisition of Prism Pharmaceuticals - http://ow.ly/4Cr0k
Baxter nabs Novartis' Hantson to lead international biz - FiercePharma
fiercepharma.com — “The mystery of Ludwig Hantson didn't last long. Yesterday, we reported that Hantson was leaving his post as North American pharma chief for an "external opportunity." And now we know that... Read more...” View full resource at fiercepharma.com
Most Recently Shared on April 16, 2010 at 2:30 pm By:
Baxter nabs Novartis' Hantson to lead international biz. http://is.gd/bvB6d
Advertisement

